Completed

Studies of Patients With Skin Disease, Patients With Neurological Degenerations, and Normal Volunteers

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being collected

Data Collection

Who is being recruted

Healthy
+2

+ Muscular Dystrophy
+ Retinal Degeneration

See all eligibility criteria

How is the trial designed

Other

Observational
Study Start: July 1978

See protocol details

Summary

Principal SponsorNational Cancer Institute (NCI)
Last updated: March 5, 2008
Sourced from a government-validated database.Claim as a partner
Study start date: July 1, 1978Actual date on which the first participant was enrolled.

It is proposed that patients with skin disease due to presumed immunologic, genetic or viral-induced abnormalities, patients with neurological degenerations, and normal controls be evaluated with various in vitro studies of immunologic, genetic, and virologic function. This is to include studies of peripheral blood (cells and serum) as well as studies of skin obtained with a biopsy instrument. In addition, studies of gastrointestinal function will be performed where appropriate. It is proposed that patients with skin disease due to presumed immunologic, genetic or viral-induced abnormalities, patients with neurological degenerations, and normal controls be evaluated with various in vitro studies of immunologic, genetic, and virologic function. This is to include studies of peripheral blood (cells and serum) as well as studies of skin obtained with a biopsy instrument. In addition, studies of gastrointestinal function will be performed where appropriate.

Official TitleStudies of Patients With Skin Disease, Patients With Neurological Degenerations, and Normal Volunteers 
Principal SponsorNational Cancer Institute (NCI)
Last updated: March 5, 2008
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria
Any sexBiological sex of participants that are eligible to enroll.
Healthy volunteers allowedIf individuals who are healthy and do not have the condition being studied can participate.
Conditions
Pathology
Healthy
Muscular Dystrophy
Retinal Degeneration
Skin Diseases
Virus Diseases
Criteria
No eligibility criteria are available at this time.Please check with the study contact for more details. 
Anonymus Profile Image
Ensure optimum compatibilityAdd your profile to know your probability eligibility score.

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.
This study has 1 location
Suspended
National Cancer Institute (NCI)Bethesda, United StatesSee the location
CompletedOne Study Center